David W. Haas

Infectious Disease

1161 21st Ave S
Nashville, TN 37232

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 157 publications

Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.

Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV.

Journal: Pharmacogenomics

Published: July 22, 2026

Pharmacogenomics of current antiretroviral drugs.

Pharmacogenomics of current antiretroviral drugs.

Journal: Pharmacogenomics

Published: May 12, 2026

Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy.

Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy.

Journal: Nature immunology

Published: April 21, 2026

Protective Effect of the APOL1 p.N264K Variant Against CKD among People with HIV Carrying APOL1 High-Risk Genotypes.

Protective Effect of the APOL1 p.N264K Variant Against CKD among People with HIV Carrying APOL1 High-Risk Genotypes.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 13, 2026

Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.

Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.

Journal: Human genetics

Published: July 28, 2025

Genetic polymorphisms and adverse reactions to antituberculosis therapy.

Genetic polymorphisms and adverse reactions to antituberculosis therapy.

Journal: Pharmacogenomics

Published: June 20, 2025

Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil.

Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil.

Journal: Memorias do Instituto Oswaldo Cruz

Published: April 07, 2025

Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.

Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy.

Journal: Open forum infectious diseases

Published: March 06, 2025

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.

Journal: Pharmacogenetics and genomics

Published: February 17, 2025

Pharmacogenomic associations with HIV-1 virologic suppression in TB/HIV patients.

Pharmacogenomic associations with HIV-1 virologic suppression in TB/HIV patients.

Journal: Research square

Published: January 07, 2025

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.

Journal: Pharmacogenetics and genomics

Published: October 29, 2024

Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.

Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.

Journal: medRxiv : the preprint server for health sciences

Published: September 10, 2024

Showing 1-12 of 157

Last Updated: 09/26/2026